ArticleRheumatology and therapy2018

Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis.

Alan Kivitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.